Skip to main content
SpringerLink
Log in

Endokrinologie und Stoffwechsel

  • Chapter
Medizin im Brennpunkt

  • 47 Accesses

Zusammenfassung

Patienten mit Diabetes mellitus entwickeln in einem hohen Prozentsatz früher oder später das Krankheitsbild einer Polyneuropathie. Sorgfältige elektrophysiologische Untersuchungen erbrachten, daß bis zu 30% der Fälle mit kindlichem oder juvenilem Diabetes Anzeichen einer peripheren Neuropathie aufweisen. Schon frühzeitig lassen sich bei dieser Altersgruppe Funktionsstörung des autonomen Nervensystems feststellen, beispielsweise Blasenstörungen in bis zu 80% und sexuelle Impotenz immerhin bis zu 30%. Bei späterer Manifestation liegt die Polyneuropathiehäufigkeit, je nach Krankheitsdauer und -typ, Einstellung etc. zwischen 13 und 50% [15].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

4.1 Gastroenterale diabetische Neuropathie

  1. Abell TL, Cutts TF, Cooper T (1993) Effect of cisapride therapy for severe dyspepsia on gastrointestinal symptoms and quality of life. Scand J Gastroenterol, Suppl 195: 60–64

    Article  CAS  Google Scholar 

  2. Bischoff A (1973) Ultrastructure pathology of peripheral nervous system in metabolic disorders. Academic Press, (Suppl 2), New York

    Google Scholar 

  3. Bretzke G (1987) Therapie der Diarrhoe bei diabetischer Enteropathie mit Clonidin. Z Gesamte Inn Med 42: 680–682

    PubMed  CAS  Google Scholar 

  4. Britland ST, Young RJ, Sharma AK et al. (1990) Vagus nerve morphology in diabetic gastropathy. Diabet Med 7: 780–787

    Article  PubMed  CAS  Google Scholar 

  5. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986

    Article  Google Scholar 

  6. Dyck PJ (1994) Personal Communication

    Google Scholar 

  7. Erckenbrecht JF, Winter HJ, Cicmir I, Wienbeck M (1988) Faecal incontinence in diabetes mellitus: It is correlated to diabetic autonomic or peripheral neuropathy. Z Gastroenterol 26: 731–736

    PubMed  CAS  Google Scholar 

  8. Fedorak RN, Field M, Chang EB (1985) Treatment of diabetic diarrhea with Clonidine. Ann Intern Med 102: 197–199

    PubMed  CAS  Google Scholar 

  9. Fehr HF (1991) Cisaprid: Erfahrungen in der Praxis bei 1071 Patienten mit Non-Ulcer-Dyspepsie (NUD) oder Refluxsympatomatik. Schweiz Med Wschr 121: 843–846

    PubMed  CAS  Google Scholar 

  10. Feldman M, Schiller LR (1983) Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 98: 378–384

    PubMed  CAS  Google Scholar 

  11. Feldman M, Smith HJ (1987) Effect of cisapride on gastric emptying of indigestible solids in patients with gastroparesis diabeticorum. A comparison with metoclopramide and placebo. Gastroenterology 92: 171–174

    PubMed  CAS  Google Scholar 

  12. Janssens J, Peeters TL, Vantrappen G et al (1990) Improvement of gastric emptying in diabetic gastroparesis by erythromycin: preliminary studies. N Engl J Med 322: 1028–1031

    Article  PubMed  CAS  Google Scholar 

  13. Jörg J, Metz F, Scharafinski H (1988) Zur medikamentösen Behandlung der diabetischen Polyneuropathie mit alpha-Liponsäure oder Vitamin B-Präparaten. Nervenarzt 59: 36–44

    PubMed  Google Scholar 

  14. Lux G (1989) Gastrointestinale Motilitätsstörungen — Diabetes mellitus. Leber Magen Darm 19: 84–93

    PubMed  CAS  Google Scholar 

  15. Neundörfer B (1987) Polyneuritiden und Polyneuropathien. Edition Medizin, VCH Verlag, Weinhein, S 352–362

    Google Scholar 

  16. Rösch W (1990) Cisaprid zur Behandlung des Reizmagens — Ergebnisse von zwei multizentrischen Studien. Z Gastroenterol (Suppl 1) 28: 36–38

    PubMed  Google Scholar 

  17. Schmidt H, Riemann JF, Schmid A, Sailer D (1984) Ultrastruktur der diabetischen autonomen Neuropathie des Gastrointestinaltraktes. Klin Wochenschr 62: 399–405

    Article  PubMed  CAS  Google Scholar 

  18. Talley NJ (1992) Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications. Aliment Pharmacol Ther 6: 273–289

    Article  PubMed  CAS  Google Scholar 

  19. Taniyama K, Nakayama S, Takeda K et al. (1991) Cisapride stimulates motility of the intestine via the 5-hydroxytryptamine receptors. J Pharmacol Exp Ther 258: 1098–1104

    PubMed  CAS  Google Scholar 

  20. WHO Lists: (1994) Suspected drug-adverse reaction associations. Cisapride S 376–378; Metoclopramide S 1157–1159

    Google Scholar 

4.2 Eingeschränkte Glukosetoleranz

  1. (1999) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 22: Suppl 1

    Google Scholar 

  2. Alberti KGMM, Zimmet PZ for the WHO consultation (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Diabet Med 15: 539–553

    Article  PubMed  CAS  Google Scholar 

4.3 Therapie des kindlichen Diabetes

  1. Gale EAM (1996) Nikotinamide: potential for the prevention of type 1 diabetes? Horm Metab Res 28 1: 361–364

    Article  CAS  Google Scholar 

  2. Persönliche Mitteilung PD Dr. Anette G. Ziegler, Institut für Diabetesforschung und Städt. Krankenhaus München-Schwabing

    Google Scholar 

  3. Seidel D, Ziegler AG (1996) Prediction of type 1 diabetes. Horm Res 45 (Suppl 1): 36–39

    Article  PubMed  CAS  Google Scholar 

  4. Ziegler AG, Bachmann W, Rabl W (1993) Prophylactic insulin treatment in relatives at high risk for type 1 diabetes. Diabetes/Metabolism Reviews 9: 286–293

    Article  Google Scholar 

4.4 Diättherapie bei Hypercholesterinämie

  1. Keys A (1970) Coronary heart disease in seven countries. Circulation XLI, XLII [Suppl I] I:186 8: 198

    Google Scholar 

  2. Kromhout D (1996) Diet-heart issue in a pharmacological era. Lancet 348: 520–522

    Article  Google Scholar 

  3. Mensink RP, Katan MB (1992) Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arteriös Thromb 12: 911–919

    Article  CAS  Google Scholar 

  4. Stephens NG, Parsons A, Schonfield PM et al. (1996) Randomised controlied trial of vitamin E in patients with coronary heart disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347: 781–786

    Article  PubMed  CAS  Google Scholar 

  5. Wolfram G (1995) Ernährungstherapie. In: Schwandt P, Richter OW (eds) Handbuch der Fettstoffwechselstörungen. Schattauer, Stuttgart New York S 541–587

    Google Scholar 

4.7 Asymptomatische Hyperurikämie

  1. Campion EW, Glynn RJ, DeLabry LO (1987) Asymptomatic hyperuricemia. Am J Med 82: 421–426

    Article  PubMed  CAS  Google Scholar 

  2. Culleton BF, Larson MG, Kannel WB, Levy D (1999) Serum uric acid and risk of cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131: 7–13

    PubMed  CAS  Google Scholar 

  3. Emmerson BT (1996) The management of gout. N Engl J Med 334: 445–451

    Article  PubMed  CAS  Google Scholar 

  4. Fessel WJ (1979) Renal Outcomes of gout and hyperuricemia. Am J Med 67: 74–82

    Article  PubMed  CAS  Google Scholar 

  5. The Coronary Drug Project Research Group (1976) Serum uric acid: its association with other risk factors and with mortality in coronary heart disease. J Chron Dis 29: 557–569

    Article  Google Scholar 

  6. Wrenger E, Bahlmann J, Floege J (1996) Harnsäure und interstitielle Nierenerkrankungen. Internist 37: 1137–1142

    PubMed  CAS  Google Scholar 

4.8 Homocystein und Atherogenese

  1. Boushey CJ et al. (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 274: 1049–1057

    Article  PubMed  CAS  Google Scholar 

  2. Glueck CJ et al. (1995) Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients. Am J Cardiol 75: 132–136

    Article  PubMed  CAS  Google Scholar 

  3. Kang S-S, Wong, PWK (1996) Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia. Atherosclerosis 119: 135–138

    Article  PubMed  CAS  Google Scholar 

  4. Malinow MR (1994) Plasma homocysteine and arterial occlusive diseases: a mini-review. Clin Chem 40: 173–176

    Google Scholar 

  5. Mayer EL et al (1996) Homocysteine and coronary atherosclerosis. JACC 27: 517–527

    PubMed  CAS  Google Scholar 

  6. Motulsky AG (1996) Invited Editorial. Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am J Hum Genet 58: 17–20

    PubMed  CAS  Google Scholar 

  7. Rasmussen et al. (1996) Age- and gender specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin Chem 42: 630–636

    PubMed  CAS  Google Scholar 

  8. von Eckardstein A et al (1994) Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men. Arterioscler Thromb 14: 960–964

    Google Scholar 

4.10 Vitaminsupplementierung

  1. ATBC Cancer Prevention Study Group (1994) The alpha-tocopherol, beta-carotene lung cancer prevention study: initial results from a controlled trial. N Engl J Med 330: 1029–1035

    Article  Google Scholar 

  2. Adolf T et al. (1994) Lebensmittel- und Nährstoffaufnahme in der Bundesrepublik Deutschland, Ergänzungsband zum Ernährungsbericht 1992 auf Basis der Nationalen Verzehrstudie. Wiss Fachverlag Dr. Fleck, Niederkleen

    Google Scholar 

  3. Biesalski HK et al. (1995) Antioxidative Vitamine in der Prävention. Dtsch Ärztebl 92: A1316–1321

    Google Scholar 

  4. Deutsche Gesellschaft für Ernährung. (1991) Empfehlungen für die Nährstoffzufuhr. Umschau Verlag, Frankfurt

    Google Scholar 

  5. Hennekens Ch, Buring J, Manson J, Stampfer M, Rosner B, Cook N, Belanger Ch, LaMotte F, Gaziano M, Ridker P, Willet W, Peto R (1966) Lack of effect of longterm supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334: 1145–1149

    Article  Google Scholar 

  6. Hodis HN, Mack WJ, LaBree L, Cashin-Hamphill L, Sevanian A, Johnson R, Azen SP (1995) Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 273: 1849–1854

    Article  PubMed  CAS  Google Scholar 

  7. Kushi L, Folsom A, Prineas R, Mink P, Wu J, Bostick R (1996) Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 334: 1156–1162

    Article  PubMed  CAS  Google Scholar 

  8. Omenn G, Goodmann G, Thornquist M et al. (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334: 1150–1155

    Article  PubMed  CAS  Google Scholar 

  9. Stephens N, Parsons A, Schofield R, Kelly F, Cheeseman K, Mitchison M, Brown M (1996) Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) 347: 781–786

    Google Scholar 

  10. Wolfram G (1994) Ist der Wert der antioxidativen Vitamine etabliert? Internist 35: 1117–1123

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurologische Universitätsklinik, Robert-Koch-Straße 40, D-37075, Göttingen, Germany

    Prof. Dr. H. Prange

  2. Abteilung Innere Medizin IV, Medizinische Klinik und Poliklinik der Universität, Otfried-Müller-Straße 10, D-72076, Tübingen, Germany

    Prof. Dr. D. Luft & Priv.-Doz. Dr. K. Rett

  3. Klinik und Poliklinik für Kinderheilkunde der, Universität Köln, Joseph-Stelzmann-Str. 9, D-50924, Köln, Germany

    Dr. Ora Seewi

  4. Klinikum Innenstadt, Medizinische Poliklinik der, Ludwig-Maximilians-Universität, Pettenkoferstr. 8a, D-80336, München, Germany

    Prof. Dr. Ch. Keller

  5. Institut für Klinische Chemie und Laboratoriumsmedizin der, Westfälischen Wilhelms-Universität, Albert-Schweitzer-Straße 33, D-48149, Münster, Germany

    Prof. Dr. G. Assmann

  6. Abteilung für Klinische Neurophysiologie der, Georg-August-Universität, Robert-Koch-Straße 40, D-37075, Göttingen, Germany

    Prof. Dr. W. Paulus

  7. Medizinische Klinik II der RWTH Aachen, Pauwelsstr. 30, D-52057, Aachen, Germany

    Prof. Dr. J. Floege

  8. Institut für Klinische Chemie und Laboratoriumsmedizin der, Westfälischen Wilhelms-Universität, Albert-Schweitzer-Straße 33, D-48149, Münster, Germany

    Priv.-Doz. Dr. A. von Eckardstein & Prof. Dr. med. G. Assmann

  9. Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein, Technische Universität München, Biedersteiner Str. 29, D-80802, München, Germany

    Priv.-Doz. Dr. F.-M. Köhn

  10. Zentrum für Dermatologie und Andrologie der, Justus-Liebig-Universität, Gaffkystr. 14, D-35385, Gießen, Germany

    Prof. Dr. Dr. habil. W.-B. Schill

  11. Institut für Ernährungswissenschaft in Weihenstephan, Technische Universität München, D-85350, Freising, Germany

    Prof. Dr. G. Wolfram

Authors
  1. Prof. Dr. H. Prange
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. D. Luft
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Priv.-Doz. Dr. K. Rett
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dr. Ora Seewi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Prof. Dr. Ch. Keller
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Prof. Dr. G. Assmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Prof. Dr. W. Paulus
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Prof. Dr. J. Floege
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Priv.-Doz. Dr. A. von Eckardstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Prof. Dr. med. G. Assmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Priv.-Doz. Dr. F.-M. Köhn
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Prof. Dr. Dr. habil. W.-B. Schill
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Prof. Dr. G. Wolfram
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. LMU München, Klinikum Großhadern Medizinische Klinik und Poliklinik III, Marchioninistraße 15, D-81377, München, Germany

    Wolfgang Hiddemann

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Prange, H. et al. (2000). Endokrinologie und Stoffwechsel. In: Hiddemann, W. (eds) Medizin im Brennpunkt. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59730-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59730-5_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-66864-0

  • Online ISBN: 978-3-642-59730-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation